Evidence map›Paper›PMID 41479656›Full record

ArticleFrontiers in nutrition2025

Jie Deng, Yuxuan Liang, Zhiming Zhang, Zhiyi Yang, Yilu Bao, Yanyan Nong, Hongmei Wang, Chenhui Zhao, Shenghong Mai, Cong Tan and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jie Deng *Shunde Polytechnic University, Foshan, China.
Yuxuan Liang *Shenzhen Key Laboratory of Food Nutrition and Health, GuangDong Engineering Technology Research Center of Aquatic Food Processing and Safety Control, College of Chemistry and Environmental Engineering and Institute for Innovative Development of Food Industry, Shenzhen University, Shenzhen, China.
Zhiming ZhangShunde Polytechnic University, Foshan, China.
Zhiyi YangShunde Polytechnic University, Foshan, China.
Yilu BaoShunde Polytechnic University, Foshan, China.
Yanyan NongShunde Polytechnic University, Foshan, China.
Hongmei WangShunde Polytechnic University, Foshan, China.
Chenhui ZhaoShunde Polytechnic University, Foshan, China.
Shenghong MaiShunde Polytechnic University, Foshan, China.
Cong TanShunde Polytechnic University, Foshan, China.
Yingxue PanShunde Polytechnic University, Foshan, China.
Caimin FengShunde Polytechnic University, Foshan, China.
Meiying LiCentral Laboratory of Panyu Central Hospital, The Affiliated Panyu Central Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Wenfeng LuoGuangdong Provincial Key Lab of Food Safety and Quality, South China Agricultural University, Guangzhou, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperuricemia (HUA) is notably prevalent in various regions. In China, it has become the second most prevalent metabolic disorder. Since the adverse effects of conventional uric acid-lowering drugs, there is an urgent need to develop natural and safe therapeutic alternatives. Previous studies have shown that

Indexed as

Konjac glucomannanLachnoclostridiumshort chain fatty acidsuric acidxanthine oxidase activity

Identifiers

PMID41479656
PMCPMC12753357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.